StageZero Life Sciences Ltd.

Good day, ladies and gentlemen, and welcome to your Stage Zero Life Sciences Second Quarter Financials Call. All lines have been placed on a listen-only mode, and the floor will be open for your questions and comments following the presentation. If you should require assistance throughout the conference, please press star zero to reach a live operator. At this time, it is my pleasure to turn the floor over to Rebecca Greco, Head of Investor Relations. Ma'am, the floor is yours.

Thank you very much. Good morning, everyone, and thank you for joining the Stage Zero second quarter 2021 conference call. Joining me today is Stage Zero CEO James Howard Tripp and Pepticel Health Clinic's chairman, Richard Houston. Please note that management's discussion today will contain forward-looking statements about anticipated results and future prospects. Forward-looking statements involve a number of risks and uncertainties, and Stage Zero's results may differ materially from those discussed today. Investors should consult the company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to those forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The company disclaims any obligation to update these forward-looking statements except as required by law. On today's call, measurement will refer to non-GAAP-adjusted EBITDA. This metric excludes certain items discussed in our press release under the heading Discussion of Non-GAAP Financial Measures. and any other items that management believes should be excluded when reviewing continuing operations. The reconciliations of Stage Zero's non-GAAP measures to the comparable GAAP measures are available in the financial tables of the Q2 2021 financial results press release on Stage Zero's website. With that introduction, I would like to turn the call over to James Howard-Tripp, Stage Zero's Chief Executive Officer. James, please go ahead.

James Howard- Thank you, Rebecca, and hello, everyone. Thank you for joining us today. To begin with, I'd like to introduce Richard Houston, who's the Chairman of PEP T-Cell, the parent company for Health Clinics Limited. Richard is to join the Stage Zero Board on closing. Welcome, Richard. It's a pleasure to work with you and the group.